By Nigam Arora & Dr. Natasha Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules
By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Pay Attention Treasury Secretary Bessent will be speaking at 10am ET about “the status of the system.” There are indications that this is not another ordinary speech. There is a high probability that
By Nigam Arora & Dr. Natasha Arora Signal(s) to enter, add, reduce, exit, hold or change. News Boston Scientific (BSX) stock is jumping 6.25% to $53.92 as of this writing on a positive surprise from ADVENT study. Farapulse Pulsed Field Ablation is a system in which electric fields selectively ablate heart tissue
Act Now If You Are Serious About Making Millions In Marijuana Thank you for registering in overwhelming numbers for the coaching seminar ‘How to Become a Marijuana Multi-Millionaire.’ Our subscribers make good financial decisions. It makes sense to take advantage of the Gold Early Bird Special to save $2,405 by
Republicans have finally produced a detailed plan to repeal and replace the Affordable Care Act, also known as Obamacare. Setting aside politics and viewing the plan neutrally, two things jump out. First, the House Republicans’ plan keeps the basic framework of Obamacare. No wonder some are calling it “Obamacare Lite.”
Mom and pop investors love to read about the stocks that billionaires have been buying or selling. The media is happy to oblige. After all, what is good for the likes of Warren Buffet and Carl Icahn has to be good for mom and pop, right? Wrong! Let me explain why it
Image by Doug Wallick via Flickr Investors are finally realizing the potential turnaround at Boston Scientific. Stock is frequently on the Most Active List and the volume is monstrous. Traditional technical analysis interprets the chart as breakout on high volume and generates a strong buy signal at this point. Our
On March 15,2010 when Boston Scientific’s defibrillators were taken off the market, the Wall Street uniformly issued downgrades. Goldman Sachs downgraded to Conviction Sell.: JP Morgan said sell, Barron’s urged investors to sell and the sell chorus chimed throughout the Wall Street. More specifically, several Gurus pronounced that the products
Typically we refrain from posting on this blog the information that is easily available elsewhere. In view of us taking long position on BSX immediately after seven broker downgrades and the importance of this FDA decision, we are making an exception. Here is the reason for Boston Scientific going up
Noble Financial’s checks at Boston Scientific indicate ICD’s and CRT-Ds could return back to the market in 5 days versus some market expectations of months. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD